E-LIB Suche - Ergebnisse für: Maldonado Perez, B

1

P740 Results at 52 weeks of Intravenous Ustekinumab as Main..:

Valdés Delgado, T ; González Antuña, J ; Javier Rodriguez González, F...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1385-i1387 , 2024

Link: https://doi.org/10.1093/..

2

P690 Monitoring ustekinumab levels in Inflammatory Bowel Di..:

González Antuña, J ; Valdés Delgado, T ; Maldonado Pérez, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1309-i1310 , 2024

Link: https://doi.org/10.1093/..

3

P081 Therapeutic Drug Monitoring of infliximab in Crohn's D..:

Valdes, T ; Vilches Arenas, A ; Maldonado Perez, B...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i181-i182 , 2022

Link: https://doi.org/10.1093/..

4

P391 Are cut-off ranges of Infliximab serum levels in Crohn..:

Valdes Delgado, T ; Guerra Veloz, M ; Belvis Jimenez, M...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S303-S304 , 2019

Link: https://doi.org/10.1093/..

5

P187 Clinical follow-up of patients with Crohn's disease tr..:

Valdes Delgado, T ; Moreno Márquez, C A ; Guerra Veloz, M F...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S187-S188 , 2019

Link: https://doi.org/10.1093/..

6

P762 Onset of inflammatory bowel disease during treatment w..:

Rodríguez Moncada, R ; Vázquez Morón, J M ; Rojas Feria, M...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S502-S502 , 2019

Link: https://doi.org/10.1093/..

7

P335 Long-term follow-up of switching from original inflixi..:

Guerra Veloz, M ; Belvis Jimenez, M ; Valdes Delgado, T...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S268-S269 , 2019

Link: https://doi.org/10.1093/..

8

Using Vedolizumab to Treat Severe Sweet's Syndrome in a Pat..:

Belvis Jiménez, M ; Maldonado Pérez, B ; Argüelles-Arias, F
Journal of Crohn's and Colitis. , 2018

Link: https://doi.org/10.1093/..

9

Infliximab as Rescue Treatment in Sweet's Syndrome Related ..:

Moreno Márquez, C ; Maldonado Pérez, B ; Castro Laria, L
Journal of Crohn's and Colitis. 12 (2018) 6 - p. 755-756 , 2018

Link: https://doi.org/10.1093/..

10

P493 Comparison of the efficacy of infliximab biosimilar (R..:

Guerra Veloz, M F ; Belvis Jimenez, M ; Valdes Delgado, T...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S354-S355 , 2018

Link: https://doi.org/10.1093/..

11

P519 Switching from reference infliximab to CT-P13 in patie..:

Guerra Veloz, M F ; Belvis Jimenez, M ; Vázquez Morón, J M...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S368-S369 , 2018

Link: https://doi.org/10.1093/..

12

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) ..:

Argüelles-Arias, F. ; Guerra Veloz, M. F. ; Perea Amarillo, R....
Digestive Diseases and Sciences. 62 (2017) 5 - p. 1305-1312 , 2017

Link: https://doi.org/10.1007/..

13

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar ..:

Argüelles-Arias, F. ; Guerra Veloz, M. F. ; Perea Amarillo, R....
Digestive Diseases and Sciences. 62 (2017) 8 - p. 2203-2203 , 2017

Link: https://doi.org/10.1007/..

14

Using Vedolizumab to Treat Severe Sweet's Syndrome in a Pat..:

Belvis Jiménez, M ; Maldonado Pérez, B ; Argüelles-Arias, F
http://hdl.handle.net/10668/12498. , 2018

Link: http://hdl.handle.net/10..

15

Infliximab as Rescue Treatment in Sweet's Syndrome Related ..:

Moreno Márquez, C ; Maldonado Pérez, B ; Castro Laria, L
http://hdl.handle.net/10668/12176. , 2018

Link: http://hdl.handle.net/10..